{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:24:44Z","timestamp":1791361484715,"version":"4.3.1"},"reference-count":29,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2022]]},"DOI":"10.5761\/atcs.oa.22-00051","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T22:22:50Z","timestamp":1657837370000},"page":"342-348","source":"Crossref","is-referenced-by-count":5,"title":["Prognosis for Mitral Valve Repair Surgery in Functional Mitral Regurgitation"],"prefix":"10.5761","volume":"28","author":[{"given":"Rafael","family":"Campos-Arjona","sequence":"first","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rodr\u00edguez-Capit\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 D.","family":"Mart\u00ednez-Carmona","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Lavreshin","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loudes","family":"Fern\u00e1ndez-Romero","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Melero-Tejedor","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Jim\u00e9nez-Navarro","sequence":"additional","affiliation":[{"name":"Department of Heart and Cardiovascular Pathology, Virgen de la Victoria University Hospital, Malaga, Spain"},{"name":"Department of Medicine and Dermatology, University of Malaga, Malaga, Spain"},{"name":"Malaga Biomedical Research Institute (IBIMA), Malaga, Spain"},{"name":"CIBERCV Cardiovascular Diseases. Carlos III Health Institute, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sannino A, Smith RL 2nd, Schiattarella GG, et al. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis. JAMA Cardiol 2017; 2: 1130\u20139.","DOI":"10.1001\/jamacardio.2017.2976"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Garc\u00eda-Cos\u00edo Carmena MD, Roig Minguell E, Ferrero-Gregori A, et al. Prognostic implications of functional mitral regurgitation in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol 2017; 70: 785\u20137.","DOI":"10.1016\/j.rec.2016.12.033"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nishimura RA, Otto CM, Bonow RO, et al. AHA\/ACC Focused Update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2017; 70: 252\u201389.","DOI":"10.1016\/j.jacc.2017.03.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Baumgartner H, Falk VJ, Bax JJ, et al. ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739\u201391.","DOI":"10.1093\/eurheartj\/ehx471"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Coats AJS, Anker SD, Baumbach A, et al. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur Heart J 2021; 42: 1254\u201369.","DOI":"10.1093\/eurheartj\/ehab086"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ponikowski PA, Voors AD, Anker S, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2129\u2013200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Petrus AHJ, Dekkers OM, Tops LF, et al. Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes. Eur Heart J 2019; 40: 2206\u201314.","DOI":"10.1093\/eurheartj\/ehz306"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nappi F, Singh SSA, Bellomo F, et al. Exploring the operative strategy for secondary mitral regurgitation: a systematic review. BioMed Res Int 2021; 2021: 3466813.","DOI":"10.1155\/2021\/3466813"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sandoval Y, Sorajja P, Harris KM. Contemporary management of ischemic mitral regurgitation: a review. Am J Med 2018; 131: 887\u201395.","DOI":"10.1016\/j.amjmed.2018.01.048"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nappi F, Avatar Singh SS, Santana O, et al. Functional mitral regurgitation: an overview for surgical management framework. J Thorac Dis 2018; 10: 4540\u201355.","DOI":"10.21037\/jtd.2018.07.07"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Dufendach K, Aranda-Michel E, Sultan I, et al. Outcomes of mitral valve surgery for severe ischemic mitral regurgitation. J Card Surg 2020; 35: 390\u20136.","DOI":"10.1111\/jocs.14395"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Wang X, Zhang B, Zhang J, et al. Repair or replacement for severe ischemic mitral regurgitation: a meta- analysis. Medicine (Baltimore) 2018; 97: e11546.","DOI":"10.1097\/MD.0000000000011546"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Maltais S, Schaff HV, Daly RC, et al. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. J Thorac Cardiovasc Surg 2011; 142: 995\u20131001.","DOI":"10.1016\/j.jtcvs.2011.07.044"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Enriquez-Sarano M, Michelena HI, Grigioni F. Treatment of functional mitral regurgitation. Circulation 2019; 139: 2289\u201391.","DOI":"10.1161\/CIRCULATIONAHA.118.038207"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nappi F, Nenna A, Mihos C, et al. Ischemic functional mitral regurgitation: from pathophysiological concepts to current treatment options. a systemic review for optimal strategy. Gen Thorac Cardiovasc Surg 2021; 69: 213\u201329.","DOI":"10.1007\/s11748-020-01562-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Calafiore AM, Totaro A, De Amicis V, et al. Surgical mitral plasticity for chronic ischemic mitral regurgitation. J Card Surg 2020; 35: 772\u20138.","DOI":"10.1111\/jocs.14487"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30: 303\u201371.","DOI":"10.1016\/j.echo.2017.01.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","DOI":"10.1080\/01621459.1999.10474144"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Timek TA, Malinowski M, Hooker RL, et al. Long-term outcomes of etiology specific annuloplasty ring repair of ischemic mitral regurgitation. Ann Cardiothorac Surg 2021; 10: 141\u20138.","DOI":"10.21037\/acs-2020-mv-fs-0166"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nappi F, Avtaar Singh SS, Padala M, et al. The choice of treatment in ischemic mitral regurgitation with reduced left ventricular function. Ann Thorac Surg 2019; 108: 1901\u201312.","DOI":"10.1016\/j.athoracsur.2019.06.039"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pang PYK, Huang MJ, Tan TE, et al. Restrictive mitral valve annuloplasty for chronic ischaemic mitral regurgitation: outcomes of flexible versus semi-rigid rings. J Thorac Dis 2019; 11: 5096\u2013106.","DOI":"10.21037\/jtd.2019.12.04"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mihos CG, Xydas S, Yucel E, et al. Mitral valve repair and subvalvular intervention for secondary mitral regurgitation: a systematic review and meta-analysis of randomized controlled and propensity matched studies. J Thorac Dis 2017; 9(Suppl 7): S582\u201394.","DOI":"10.21037\/jtd.2017.05.56"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Monteagudo Ruiz JM, Zamorano G\u00f3mez JL. Importance of the left ventricle in secondary mitral regurgitation. hunt with cats and you catch only rats. Rev Esp Cardiol 2019; 72: 994\u20137.","DOI":"10.1016\/j.rec.2019.08.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ji Q, Zhao Y, Shen J, et al. Predictors of ischemic mitral regurgitation improvement after surgical revascularization plus mitral valve repair for moderate ischemic mitral regurgitation. J Card Surg 2020; 35: 528\u201335.","DOI":"10.1111\/jocs.14455"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Troubil M, Marcian P, Gwozdziewicz M, et al. Predictors of failure following restrictive annuloplasty for chronic ischemic mitral regurgitation. J Card Surg 2012; 27: 6\u201312.","DOI":"10.1111\/j.1540-8191.2011.01342.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Onorati F, Rubino AS, Marturano D, et al. Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2009; 138: 654\u201362.","DOI":"10.1016\/j.jtcvs.2009.01.020"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kron IL, Hung J, Overbey JR, et al. Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2015; 149: 752\u201361.e1.","DOI":"10.1016\/j.jtcvs.2014.10.120"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Suri RM, Clavel MA, Schaff HV, et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol 2016; 67: 488\u201398.","DOI":"10.1016\/j.jacc.2015.10.098"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tatum JM, Bowdish ME, Mack WJ, et al. Outcomes after mitral valve repair: a single-center 16-year experience. J Thorac Cardiovasc Surg 2017; 154: 822\u2013 30.e2.","DOI":"10.1016\/j.jtcvs.2017.01.047"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/28\/5\/28_oa.22-00051\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:36:17Z","timestamp":1715315777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/28\/5\/28_oa.22-00051\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.oa.22-00051","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"oa.22-00051"}}